Claritas Pharmaceuticals Inc V.CLAS

Primary Symbol: V.CLAS.H Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Past History

<< Previous

Bullboard Posts

Next >>

Post by HighSkies2019on Mar 04, 2021 2:17pm

108 Views

Post# 32716911

Past History

No offense to anyone ....but we have been on a halt since last June and just unhalted last Friday ....we have come along way for those of us who believe this stk play with our recent news ..we suffered the long gevity of the 8mos halt.... as for seeing posts couple years past and negative comments .... has nothing to do with our future.... read our nr ln sedar and make your own decisions .... I believe in the future of my stk play... this is imo ... glta

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida